New version of CIEL dictionary has been added to dropbox and on Open Concept Lab for November 24, 2024!
Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.6, 2.0.1, 2.1, 2.2, 2.3, 2.4.5 and 2.5.5. Note that I will no longer be releasing in versions prior to 1.11
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).
If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.
Be sure to read the wiki: om.rs/getciel
NOTE THAT THE DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.
Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.
The release includes more new concepts for the Ref App, PIH, Uganda and Kenya. WHO ATC codes continue to be added to existing medication concepts. There are now close to 3600 ICD-11 codes, and these are being added incrementally. New FDA-approved drugs have been added.
The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.
The list of new concepts (English names): |concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|169528|Cannabis withdrawal|Diagnosis|N/A||
|169527|Caffeine withdrawal|Diagnosis|N/A||
|169526|Disseminated Lyme disease|Diagnosis|N/A||
|169526|Disseminated Lyme borreliosis|Diagnosis|N/A||
|169526|Disseminated infection caused by Borrelia|Diagnosis|N/A||
|169525|Tuberculosis of lung, confirmed histologically|Diagnosis|N/A||
|169524|Ameboma of intestine|Diagnosis|N/A||
|169523|Source type of infection|Question|Coded||
|169522|Community associated infectious disease|Diagnosis|N/A||
|169522|Community acquired infection|Diagnosis|N/A||
|169521|Zone of inhibition (mm)|Question|Numeric||
|169521|ZOI|Question|Numeric||
|169520|Abrasion of lower back|Diagnosis|N/A||
|169519|Skinned knee|Diagnosis|N/A||
|169519|Abrasion of knee|Diagnosis|N/A||
|169518|Secukinumab|Drug|N/A||
|169518|Cosentyx|Drug|N/A||
|169517|makan pinang|Diagnosis|N/A||
|169517|Pan masala|Diagnosis|N/A||
|169517|Betel nut abuse|Diagnosis|N/A||
|169517|Areca nut abuse|Diagnosis|N/A||
|169516|Miplyffa|Drug|N/A||
|169516|Arimoclomol|Drug|N/A||
|169515|Cobenfy|Drug|N/A||
|169515|Trospium / xanomeline|Drug|N/A||
|169514|Itovebi|Drug|N/A||
|169514|Inavolisib|Drug|N/A||
|169513|Zolbetuximab-clzb|Drug|N/A||
|169513|Vyloy|Drug|N/A||
|169512|Molluscum pendulum|Diagnosis|N/A||
|169512|Molluscum fibrosum pendulum|Diagnosis|N/A||
|169511|Vasectomy status|Diagnosis|N/A||
|169511|History of vasectomy|Diagnosis|N/A||
|169510|Sexually transmitted disease in male|Diagnosis|N/A||
|169510|STI,males|Diagnosis|N/A||
|169510|STI (sexually transmitted infection) in male|Diagnosis|N/A||
|169509|S4 gallop|Diagnosis|N/A||
|169508|Muscle weakness RUE|Diagnosis|N/A||
|169508|Muscle weakness of right upper extremity|Diagnosis|N/A||
|169507|Muscle weakness of left upper extremity|Diagnosis|N/A||
|169507|Muscle weakness LUE|Diagnosis|N/A||
|169506|Muscle weakness RLE|Diagnosis|N/A||
|169506|Muscle weakness of right lower extremity|Diagnosis|N/A||
|169505|Muscle weakness of left lower extremity|Finding|N/A||
|169505|Muscle weakness LLE|Finding|N/A||
|169504|Muscle atrophy of left upper extremity|Diagnosis|N/A||
|169504|Muscle atrophy LUE|Diagnosis|N/A||
|169503|Muscle atrophy RUE|Diagnosis|N/A||
|169503|Muscle atrophy of right upper extremity|Diagnosis|N/A||
|169502|Muscle atrophy of right lower extremity|Diagnosis|N/A||
|169502|Muscle atrophy RLE|Diagnosis|N/A||
|169501|Muscle atrophy of left lower extremity|Diagnosis|N/A||
|169501|Muscle atrophy LLE|Diagnosis|N/A||
|169500|Diffuse muscle atrophy|Diagnosis|N/A||
|169499|Troponin T high sensitivity rapid test|Test|Coded||
|169498|Decreased sensation, generalized|Diagnosis|N/A||
|169498|Decreased sensation, diffuse|Diagnosis|N/A||
|169497|Vocal fremitus decreased|Finding|N/A||
|169496|Blue nail bed|Finding|N/A||
|169496|Blue nails|Finding|N/A||
|169495|Urine microscopy for uric acid crystals|Test|Coded||
|169494|Urine microscopy for mucus|Test|Coded||
|169493|Urine mucus|Finding|N/A||
|169492|Urine microscopy for triple phosphate crystals|Test|Coded||
|169492|Urine microscopy for magnesium ammonium phosphate crystals|Test|Coded||
|169491|Urine microscopy for calcium oxalate crystals|Test|Coded||
|169490|Urine microscopy for amorphous urate crystals|Test|Coded||
|169489|Urine microscopy for amorphous phosphate crystals|Test|Coded||
|169488|Urine microscopy for ammonium urate crystals|Test|Coded||
|169487|Final tracing outcome|Question|Coded||
|169486|Contact attempt detail|ConvSet|N/A||
|169485|Has sufficient medication|Finding|N/A|Patient has sufficient medication for treatment|
|169484|Public health restrictions|Misc|N/A|Restrictions on movement or exposure for public health reasons (such as quarantine, stay-at-home when sick orders, etc.)|
|169483|Unable to get time off from work or school|Finding|N/A||
|169482|Reason for not attending health care visit (coded)|Question|Coded||
|169482|Reason for missed visit (coded)|Question|Coded||
|169481|HIV disclosure detail|ConvSet|N/A||
|169480|Abdominal mass LUQ|Diagnosis|N/A||
|169480|Abdominal mass, left upper quadrant|Diagnosis|N/A||
|169479|Abdominal mass, right upper quadrant|Diagnosis|N/A||
|169479|Abdominal mass RUQ|Diagnosis|N/A||
|169478|Abdominal mass RLQ|Diagnosis|N/A||
|169478|Abdominal mass, right lower quadrant|Diagnosis|N/A||
|169477|Abdominal mass LLQ|Diagnosis|N/A||
|169477|Abdominal mass, left lower quadrant|Diagnosis|N/A||
|169476|History of voluntary skin bleaching|Diagnosis|N/A||
|169476|History of voluntary skin depigmentation|Diagnosis|N/A||
|169476|History of voluntary skin whitening|Diagnosis|N/A||
|169476|Depigmentation of skin due to cosmetic procedure|Diagnosis|N/A||
|169475|Troponin I measurement, rapid|Test|Coded||
|169474|Timed up and go mobility test score|Question|Numeric||
|169473|Berg Balance Scale score|Question|Numeric||
|169472|Application of Berg Balance Scale|Procedure|N/A||
|169471|Berg Balance Scale|Misc|N/A||
|169470|Victim of physical threats|Question|Coded||
|169469|HIV protease inhibitors (PIS)|Pharmacologic Drug Class|N/A||
|169468|Non-nucleoside reverse transcriptase inhibitors (NNRTIS)|Pharmacologic Drug Class|N/A||
|169467|Nucleotide reverse transcriptase inhibitors|Pharmacologic Drug Class|N/A||
|169467|Nucleoside reverse transcriptase inhibitors (NRTIS)|Pharmacologic Drug Class|N/A||
|169466|Datetime of verification|Question|Datetime||
|169465|Transfer out verification complete|Question|Coded||
|169464|Lamivudine / nevirapine / stavudine regimen|Misc|N/A|ARV regimen|
|169464|d4T + 3TC + NVP|Misc|N/A|ARV regimen|
|169463|3TC / AZT / RAL|Misc|N/A|ARV regimen|
|169463|Lamivudine / Raltegravir / Zidovudine regimen|Misc|N/A|ARV regimen|
|169463|AZT + 3TC + RAL|Misc|N/A|ARV regimen|
|169462|Abacavir / Dolutegravir / Lamivudine regimen|Misc|N/A|ARV regimen|
|169462|ABC + 3TC + DTG regimen|Misc|N/A|ARV regimen|
|169462|ABC / 3TC / DTG|Misc|N/A|ARV regimen|
|169461|Uniformed services|Misc|N/A|Includes not only armed forces, but also police, fire, etc.|
|169460|ABC + 3TC + DRV/r|Misc|N/A|ARV regimen|
|169460|Abacavir / Darunavir / Lamivudine / Ritonavir|Misc|N/A|ARV regimen|
|169459|Abacavir / Atazanavir / Lamivudine / Ritonavir|Misc|N/A|ARV regimen|
|169459|ABC + 3TC + ATV/r|Misc|N/A|ARV regimen|
|169458|AZT + 3TC + NVP|Misc|N/A|ARV regimen|
|169458|3TC / AZT / NVP|Misc|N/A|ARV regimen|
|169458|Lamivudine / nevirapine / zidovudine regimen|Misc|N/A|ARV regimen|
|169457|Dolutegravir / lamivudine / tenofovir alafenamide regimen|Misc|N/A|ARV regimen|
|169457|TAF + 3TC + DTG|Misc|N/A|ARV regimen|
|169456|Etravirine + lamivudine + darunavir + ritonavir|Misc|N/A|AFV regimen|
|169456|Darunavir / etravirine / lamivudine / ritonavir|Misc|N/A|AFV regimen|
|169456|ETV + 3TC + DRV + RTV|Misc|N/A|AFV regimen|
|169455|Raltegravir + lamivudine + darunavir + ritonavir|Misc|N/A|ARV regimen|
|169455|Darunavir / lamivudine / raltegravir / ritonavir|Misc|N/A|ARV regimen|
|169455|RAL + 3TC + DRV + RTV|Misc|N/A|ARV regimen|
|169454|Darunavir / lamivudine / ritonavir / tenofovir alafenamide|Misc|N/A|ARV regimen|
|169454|TAF + 3TC + DRV/r|Misc|N/A|ARV regimen|
|169453|Binge eating disorder|Diagnosis|N/A||
|169453|BED (binge eating disorder)|Diagnosis|N/A||
|169452|Palmoplantar keratoderma|Diagnosis|N/A||
|169451|Onychomatricoma|Diagnosis|N/A||
|169450|FM (frictional melanosis)|Diagnosis|N/A||
|169450|Frictional melanosis|Diagnosis|N/A||
|169449|Papulopustular acne vulgaris|Diagnosis|N/A||
|169449|Superficial inflammatory acne vulgaris|Diagnosis|N/A||
|169448|Retentional acne|Diagnosis|N/A||
|169447|Exogenous ochronosis|Diagnosis|N/A||
|169447|EO (exogenous ochronosis)|Diagnosis|N/A||
|169446|Paraneoplastic pruritus|Diagnosis|N/A||
|169446|Paraneoplastic itch|Diagnosis|N/A||
|169445|Lichen planus actinicus|Diagnosis|N/A||
|169445|Actinic lichen planus|Diagnosis|N/A||
|169444|Extreme prematurity, 27 weeks|Diagnosis|N/A||
|169444|Gestation period, 27 weeks|Diagnosis|N/A||
|169443|Bronchial pneumonia|Diagnosis|N/A||
|169443|Pneumonia, bronchial|Diagnosis|N/A||
|169443|Bronchopneumonia|Diagnosis|N/A||
|169442|XEC variant|Misc|N/A|SARS-CoV-2 (COVID-19) virus variant|
|169441|TAF + 3TC + LPV/r|Misc|N/A|ART regimen|
|169441|Lamivudine / Lopinavir / Ritonavir / Tenofovir alafenamide|Misc|N/A|ART regimen|
|169440|TDF + 3TC + DTG + ETR + DRV + RTV|Misc|N/A|This is an ART regimen consisting of Tenofovir + Lamivudine + Dolutegravir + Etravirine + Darunavir + Ritonavir|
|169440|TDF/3TC/DTG/ETV/DRV/RTV|Misc|N/A|This is an ART regimen consisting of Tenofovir + Lamivudine + Dolutegravir + Etravirine + Darunavir + Ritonavir|
|169440|Darunavir / Dolutegravir / Etravirine / Lamivudine / Ritonavir / Tenofovir|Misc|N/A|This is an ART regimen consisting of Tenofovir + Lamivudine + Dolutegravir + Etravirine + Darunavir + Ritonavir|
|169439|DTG+FTC+TDF|Misc|N/A|ART regimen|
|169439|Dolutegravir / emtricitabine / tenofovir disoproxil regimen|Misc|N/A|ART regimen|
|169438|Nutrition services|Misc|N/A||
|169437|EFV+FTC+TDF|Misc|N/A|ART regimen|
|169437|Efavirenz / emtricitabine / tenofovir disoproxil regimen|Misc|N/A|ART regimen|